Company Comparison
Portola Pharmaceuticals vs 54gene
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Portola Pharmaceuticals | 54gene |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | South San Francisco, California | Lagos, Nigeria |
| Founded | 2003 | 2019 |
| Status | Active | Active |
| Last Funding Stage | — | Series B |
| Total Funding | — | $45M |
| Valuation | — | — |
What They Build
Portola Pharmaceuticals
Portola Pharmaceuticals is an American clinical stage biotechnology company that researches, develops, and commercializes drugs.
54gene
African genomics research company advancing precision medicine through genetic research focused on African populations.
Key Investors
Portola Pharmaceuticals
Sector Overlap
Both Portola Pharmaceuticals and 54gene operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.